A framework for prediction of response to HCV therapy using different data mining techniques

Enas M F El Houby1

  • 1Engineering Division, Systems & Information Department, National Research Centre, El Buhouth Street, Dokki, Cairo 12311, Egypt.

Insights

Predicting Hepatitis C treatment response is crucial due to low efficacy and high costs of current therapies. This study developed a framework to identify the best predictive model using clinical data, improving patient outcomes.

Area of Science:

  • Hepatology
  • Medical Informatics
  • Data Mining

Background:

  • Hepatitis C Virus (HCV) infection is a global health concern, leading to fatal liver disease.
  • Current interferon plus ribavirin therapy for HCV has limited response rates, high costs, and significant side effects.
  • Predicting treatment response is essential to minimize patient exposure to ineffective treatments and associated burdens.

Purpose of the Study:

  • To develop and evaluate a framework for selecting the optimal data mining model to predict patient response to Hepatitis C treatment.
  • To identify key clinical factors that contribute to predicting treatment success.

Main Methods:

  • A three-phase framework was implemented: data preprocessing, data mining, and model evaluation.
  • Data mining techniques including associative classification, artificial neural networks, and decision trees were applied.
  • Model performance was rigorously evaluated to select the most effective predictive model.

Main Results:

  • The developed framework effectively identified the best model for predicting Hepatitis C treatment response.
  • Associative classification, utilizing histology activity index, fibrosis stage, and alanine amino transferase, emerged as the superior predictive model.
  • The experimental results demonstrated the framework's capability in selecting a highly effective predictive model.

Conclusions:

  • The proposed framework offers a robust method for selecting optimal predictive models for Hepatitis C treatment response.
  • Utilizing specific clinical indicators with associative classification can significantly enhance prediction accuracy.
  • This approach can guide clinical decisions, leading to more personalized and effective Hepatitis C management strategies.

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
582
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
327
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
400
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
266
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
364